Express Learning Breakout
O2 — Clinically Indicated Site Rotation: Steps and Data to Strive for Success - The Journey Continues
Tuesday, September 18
11:15 AM - 11:45 AM
Presentation CE Credits: 1 for two (2) 30-min Breakouts
This presentation would be helpful to both attendees that have implemented CISR in addition to those who are considering implementation. It includes steps in the journey at our facility including improvements in removal reasons documentation and data collection. It also includes tracking and monitoring of PIV complication rates according to grade and dwell time for both phlebitis and infiltration in addition to BSI rates. Our IV Therapy Team currently does a daily PIV site assessment on patients whose PIV has dwelled >96 hours. Results show there was no significant difference in phlebitis rates before and after the practice change. We continue to monitor BSIs to ensure there is no correlation with any increase in BSI rates associated with Clinically Indicated Site Rotation. Discussion continues concerning the impact of individual hospital peripheral IV insertion practices/products, the possibility of removing the daily PIV assessment by the IV Team, and next steps prior to moving the practice change system wide. The Clinically Indicated Site rotation research project at our facility has resulted in a significant savings in supplies, vessel preservation, and increased patient satisfaction.
- Discuss the importance of accurate peripheral IV removal reasons documentation and data collection to track complication rates.
- Discuss the importance of monitoring peripheral IV phlebitis and infiltration rates according to grade and dwell time in addition to BSI rates.
- Discuss our current practice of IV Therapy daily site assessment of peripheral IV's dwelling greater than 96 hours.
- Discuss the impact of individual hospital peripheral IV insertion practices and products on Clinically Indicated Site Rotation.